# Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation

> **NCT03395574** · PHASE2 · COMPLETED · sponsor: **Kasr El Aini Hospital** · enrollment: 30 (actual)

## Conditions studied

- Terlipressin Adverse Reaction
- Liver Transplantation

## Interventions

- **DRUG:** Terlipressin
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03395574
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-25
- **Primary completion:** 2018-11-25
- **Final completion:** 2018-11-25
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03395574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03395574, "Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT03395574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*